Latvia vs Pakistan: HIV-positive TB patients on ART (antiretroviral therapy)
Latvia
70.0%
in 2017
Pakistan
70.0%
in 2024
Latvia rank
125th
Pakistan rank
125th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Latvia
- Pakistan
How they compare
Latvia currently reports 70.0% against 70.0% in Pakistan, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2008 it was Pakistan ahead.
Latvia ranks 125th and Pakistan ranks 125th of 144 countries.
Pakistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Latvia | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.5% | 69.5% | 25.0% | Pakistan |
| 2010s | 62.9% | 83.9% | 21.0% | Pakistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Latvia or Pakistan?
- Latvia, at 70.0% against 70.0% in Pakistan as of 2017.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Latvia and Pakistan?
- 0.0%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Pakistan?
- 10 years are reported by both, from 2008 to 2017.
- How do Latvia and Pakistan rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Latvia ranks 125th and Pakistan ranks 125th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.